Aurora Cannabis (ACB) EBT Margin (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly EBT Margin of 44.89% for Q1 2026, down 4250.0% year-on-year from 1.08% in Q1 2025, and down 3186.05% on a QoQ basis from 1.37% in Q4 2025.
Aurora Cannabis (ACB) EBT Margin (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported EBT Margin for 10 consecutive years, with 44.89% the latest figure, recorded in Q1 2026.
- Quarterly EBT Margin fell 4250.0% year-over-year to 44.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28.71% (down 3353.0% YoY) and the FY2026 annual result came in at 37.48%, down 4831.0% from the prior year.
- EBT Margin declined to 44.89% in Q1 2026 per ACB's latest filing, from 1.37% in the prior quarter.
- Over the last five years, EBT Margin for ACB reached as high as 63.74% in Q1 2024 and fell as low as 1998.51% in Q1 2022.
- A 5-year average of 341.21% and a median of 23.19% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin plunged 169869 bps — and 2024, when it surged 104600 bps.
- Year by year, EBT Margin stood at 457.44% in 2022, then jumped by 94 bps to 26.6% in 2023, then jumped by 218 bps to 31.44% in 2024, then plunged by 104 bps to 1.37% in 2025, then plunged by 3186 bps to 44.89% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 44.89%, 1.37%, and 51.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | -44.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.89% |
| Dec 31, 2025 | -1.37% |
| Sep 30, 2025 | -51.98% |
| Jun 30, 2025 | -19.77% |
| Mar 31, 2025 | -2.38% |
| Dec 31, 2024 | 31.44% |
| Sep 30, 2024 | 0.21% |
| Jun 30, 2024 | 2.14% |
| Mar 31, 2024 | 63.74% |
| Dec 31, 2023 | -26.60% |
| Sep 30, 2023 | 0.10% |
| Jun 30, 2023 | -1,043.86% |
| Dec 31, 2022 | -457.44% |
| Sep 30, 2022 | -676.20% |
| Jun 30, 2022 | -1,233.91% |
| Mar 31, 2022 | -1,998.51% |
| Dec 31, 2021 | -124.63% |
| Sep 30, 2021 | -20.12% |
| Jun 30, 2021 | 68.24% |
| Mar 31, 2021 | -299.82% |